These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23428846)

  • 1. Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France.
    Peyriere H; Eiden C; Micallef J; Lapeyre-Mestre M; Faillie JL; Blayac JP
    Eur Addict Res; 2013; 19(5):235-44. PubMed ID: 23428846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OPPIDUM surveillance program: 20 years of information on drug abuse in France.
    Frauger E; Moracchini C; Le Boisselier R; Braunstein D; Thirion X; Micallef J;
    Fundam Clin Pharmacol; 2013 Dec; 27(6):672-82. PubMed ID: 23510229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abuse Liability of Quetiapine (Xeroquel®)].
    Peyrière H; Diot C; Eiden C; Petit P;
    Therapie; 2015 Aug; ():. PubMed ID: 26242499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey.
    Boeuf O; Lapeyre-Mestre M;
    Drug Saf; 2007; 30(3):265-76. PubMed ID: 17343432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 17983559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of slow-release morphine sulfate abuse and diversion: epidemiological approaches in a French administrative area.
    Peyriere H; Nogue E; Eiden C; Frauger E; Charra M; Picot MC;
    Fundam Clin Pharmacol; 2016 Oct; 30(5):466-75. PubMed ID: 27315486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network].
    Frauger E; Pochard L; Boucherie Q; Giocanti A; Chevallier C; Daveluy A; Gibaja V; Caous AS; Eiden C; Authier N; Le Boisselier R; Guerlais M; Jouanjus É; Lepelley M; Pizzoglio V; Pain S; Richard N; Micallef J;
    Therapie; 2017 Sep; 72(4):491-501. PubMed ID: 28343650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on zolpidem abuse and dependence.
    Victorri-Vigneau C; Gérardin M; Rousselet M; Guerlais M; Grall-Bronnec M; Jolliet P
    J Addict Dis; 2014; 33(1):15-23. PubMed ID: 24467433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].
    Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M
    Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
    Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
    Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate.
    Micallef J; Frauger E; Palmaro A; Boucherie Q; Lapeyre Mestre M
    Therapie; 2015; 70(2):191-202. PubMed ID: 25858575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-marketing surveillance systems for psychoactive prescription drug abuse].
    Nordmann S; Frauger E; Pauly V; Rouby F; Mallaret M; Micallef J; Thirion X
    Therapie; 2011; 66(3):263-72. PubMed ID: 21819810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neocodion misuse: evolution between 1992 and 2002].
    Armand C; Thirion X; Saillard C; Lapeyre-Mestre M; Lambert H
    Therapie; 2004; 59(5):547-53. PubMed ID: 15648308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program].
    Pauly V; Frauger E; Rouby F; Sirere S; Monier S; Paulet C; Gibaga V; Micallef J; Thirion X
    Encephale; 2010 Apr; 36(2):122-31. PubMed ID: 20434629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France.
    Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uro- and nephrotoxic effects of drugs of abuse: Literature review and pharmaco-epidemiological survey in France and in the Marseille area].
    Gully M; Frauger É; Spadari M; Pochard L; Pauly V; Romain F; Gondouin B; Sallée M; Moussi-Frances J; Burtey S; Dussol B; Daniel L; Micallef J; Jourde-Chiche N
    Nephrol Ther; 2017 Nov; 13(6):429-438. PubMed ID: 28958905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.
    Garnier C; Schein M; Lacroix C; Jouve E; Soeiro T; Gentile G; Lapeyre Mestre M; Micallef J
    CNS Drugs; 2024 Sep; 38(9):743-751. PubMed ID: 38990472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.
    Frauger E; Pauly V; Pradel V; Rouby F; Arditti J; Thirion X; Lapeyre Mestre M; Micallef J
    Fundam Clin Pharmacol; 2011 Oct; 25(5):633-41. PubMed ID: 21077937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early signal of diverted use of tropicamide eye drops in France.
    Ponté C; Pi C; Palmaro A; Jouanjus E; Lapeyre-Mestre M;
    Br J Clin Pharmacol; 2017 Aug; 83(8):1791-1800. PubMed ID: 28239898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 27393493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.